Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Executive Team
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Contact Us
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Publications

Apr 28, 2022

Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing Galanthus nivalis Agglutinin

Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection
Oct 8, 2021

Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection

Lectin Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein Elimination
Apr 26, 2018

Lectin Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein Elimination

 Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease – First Experience with Lectin Affinity Plasmapheresis
Feb 11, 2015

Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease – First Experience with Lectin Affinity Plasmapheresis

Exosome removal as a therapeutic adjuvant in cancer
Jun 27, 2012

Exosome removal as a therapeutic adjuvant in cancer

Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity Plasmapheresis
Jan 8, 2010

Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity Plasmapheresis

Reduction of Hepatitis C Virus Using Lectin Affinity Plasmapheresis in Dialysis Patients
Jan 23, 2009

Reduction of Hepatitis C Virus Using Lectin Affinity Plasmapheresis in Dialysis Patients

  • Linkedin
Privacy Policy Disclaimer Sitemap
© 2023 Aethlon Medical, Inc. All Rights Reserved.